A recent article in the Capital Business Journal, a Washington Post publication, about diversifying the local economy included information about how Children’s National is using data to help improve care for children with chronic conditions like sickle cell disease.
Read the article
Want the latest Children’s National news and stories as they happen? Sign up to get our News & Events releases by email.
The hip program at Children’s National has a reputation for delivering advanced surgical care and leading breakthrough research in pediatric hip disorders.
Cellular therapy is a novel treatment for reducing infection and relapse in children with blood cancers.
Our blood and marrow transplant offers trials for cellular therapy to reduce infection and relapse in children with cancer
Children’s National Health System holds a Sickle Cell Disease Education Symposium each November to educate families about breakthroughs in sickle cell disease treatment and clinical updates.